Dyne Therapeutics, Inc.
DYN
$9.57
-$0.48-4.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -115.36M | -89.54M | -97.13M | -65.10M | -65.65M |
| Total Depreciation and Amortization | 502.00K | 450.00K | 438.00K | 399.00K | 386.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.57M | 9.84M | 7.88M | 5.59M | 19.55M |
| Change in Net Operating Assets | -3.60M | -5.09M | 14.18M | 4.24M | -32.83M |
| Cash from Operations | -105.89M | -84.34M | -74.63M | -54.87M | -78.54M |
| Capital Expenditure | -981.00K | -1.08M | -253.00K | -857.00K | -191.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.44M | -14.94M | -19.15M | 12.03M | -179.65M |
| Cash from Investing | 1.46M | -16.01M | -19.40M | 11.17M | -179.84M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 141.24M | 3.64M | 18.01M | 379.86M | 408.39M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 141.24M | 3.64M | 18.01M | 379.86M | 408.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.81M | -96.71M | -76.02M | 336.17M | 150.01M |